GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bal Pharma Ltd (NSE:BALPHARMA) » Definitions » Gross-Profit-to-Asset %

Bal Pharma (NSE:BALPHARMA) Gross-Profit-to-Asset % : 42.77% (As of Dec. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bal Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Bal Pharma's annualized Gross Profit for the quarter that ended in Dec. 2024 was ₹1,452 Mil. Bal Pharma's average Total Assets over the quarter that ended in Dec. 2024 was ₹3,395 Mil. Therefore, Bal Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 42.77%.


Bal Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Bal Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bal Pharma Gross-Profit-to-Asset % Chart

Bal Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.12 39.39 44.70 43.74 41.46

Bal Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 43.43 30.73 44.17 42.06 42.77

Competitive Comparison of Bal Pharma's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bal Pharma's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Bal Pharma's Gross-Profit-to-Asset % falls into.


;
;

Bal Pharma Gross-Profit-to-Asset % Calculation

Bal Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=1311.59/( (3131.723+3195.255)/ 2 )
=1311.59/3163.489
=41.46 %

Bal Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=1451.996/( (3395.064+0)/ 1 )
=1451.996/3395.064
=42.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Bal Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Bal Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bal Pharma Business Description

Traded in Other Exchanges
Address
10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives. It offers products in dosage forms, such as tablets, capsules, syrups, suspensions, creams, and ointments, to various markets.

Bal Pharma Headlines

No Headlines